On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on “Exploring Alternatives to Fetal Tissue Research.” The hearing was called as the U.S. Department of Health and Human Services re-evaluates funding for research using tissue from aborted babies. Charlotte Lozier Institute’s Vice President and Research Director David A. Prentice, Ph.D., submitted the following written testimony in support of using ethical alternatives to aborted fetal tissue research.

 

To view Prentice’s testimony in PDF format, please see, “Written Testimony of David A. Prentice, Ph.D., In Support of Ethical Alternatives to Aborted Fetal Tissue Research.”